Clinical trial reportThyroid : official journal of the American Thyroid AssociationPublished
Increased Progression-Free Survival with Cabozantinib Versus Placebo in Patients with Radioiodine-Refractory Differentiated Thyroid Cancer Irrespective of Prior Vascular Endothelial Growth Factor Receptor-Targeted Therapy and Tumor Histology: A Subgroup Analysis of the COSMIC-311 Study
Regional connection
Verified An author affiliation on the Europe PMC record names University of Pennsylvania. Affiliation source
- Institution
- University of Pennsylvania
- County
- Philadelphia County
Publication record
- Type
- Clinical trial report
- Venue
- Thyroid : official journal of the American Thyroid Association
- Published
- Topic
- Clinical care
- Subject terms
- Humans; Adenocarcinoma; Thyroid Neoplasms; Iodine Radioisotopes; Anilides; Phenylurea Compounds; Pyridines; Quinolines; Receptors, Vascular Endothelial Growth Factor; Vascular Endothelial Growth Factor A; Antineoplastic Agents; Protein Kinase Inhibitors
- PubMed ID
- 38062732
- PubMed Central ID
- PMC10951569
- Open access
- Yes, open
- Added to directory
- Source checked